Immunology, Antibody, Receptor, Immune system and Monoclonal antibody are his primary areas of study. His work on Immunology is being expanded to include thematically relevant topics such as Immune complex disease. In his study, which falls under the umbrella issue of Antibody, CD28 and Human immunoglobulin is strongly linked to Molecular biology.
His Receptor study incorporates themes from Inflammation, Arthus reaction, Phagocytosis and Autoimmunity. His Immune system research is multidisciplinary, relying on both Degranulation and Cell biology. J. Sjef Verbeek focuses mostly in the field of Antigen, narrowing it down to topics relating to Antigen presentation and, in certain cases, MHC class I and CD8.
J. Sjef Verbeek spends much of his time researching Immunology, Receptor, Antibody, Immune system and Molecular biology. His study in Monoclonal antibody, Complement system, Autoantibody, T cell and Arthritis is done as part of Immunology. His Receptor study combines topics from a wide range of disciplines, such as Cancer research, Inflammation, Immunoglobulin G, Immune complex and Autoimmunity.
The study incorporates disciplines such as Knockout mouse, Heligmosomoides polygyrus, Signal transduction and Immunotherapy in addition to Antibody. His biological study spans a wide range of topics, including In vivo, Pathogenesis and Antigen. His Antigen research includes themes of Cytotoxic T cell and Antigen presentation.
His scientific interests lie mostly in Molecular biology, Antibody, Immune system, Receptor and Immunology. His Molecular biology study combines topics in areas such as Dendritic cell, Antigen presentation and B cell. A large part of his Antibody studies is devoted to Monoclonal antibody.
His studies in Immune system integrate themes in fields like Cancer research, Antigen and Effector. While the research belongs to areas of Receptor, J. Sjef Verbeek spends his time largely on the problem of Macrophage, intersecting his research to questions surrounding Bone marrow, Osteoclast, Inflammation, Arthritis and Flow cytometry. J. Sjef Verbeek conducts interdisciplinary study in the fields of Immunology and Corneal neovascularization through his works.
His primary scientific interests are in CD8, Molecular biology, Cancer research, Immunotherapy and Monoclonal antibody. The Molecular biology study combines topics in areas such as T cell, Lymphatic system and Genetically modified mouse. Within one scientific family, J. Sjef Verbeek focuses on topics pertaining to Interleukin 10 under Cancer research, and may sometimes address concerns connected to Receptor.
To a larger extent, J. Sjef Verbeek studies Immune system with the aim of understanding Immunotherapy. His work on Ofatumumab as part of his general Monoclonal antibody study is frequently connected to Vascular endothelial growth factor A, thereby bridging the divide between different branches of science. His Antibody study frequently draws connections between related disciplines such as Cytotoxic T cell.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Fcγ Receptor–mediated Induction of Dendritic Cell Maturation and Major Histocompatibility Complex Class I–restricted Antigen Presentation after Immune Complex Internalization
Armelle Regnault;Danielle Lankar;Valérie Lacabanne;Ana Rodriguez.
Journal of Experimental Medicine (1999)
Arthritis Critically Dependent on Innate Immune System Players
Hong Ji;Hong Ji;Koichiro Ohmura;Koichiro Ohmura;Umar Mahmood;David M Lee.
Dectin-2 is a Syk-coupled pattern recognition receptor crucial for Th17 responses to fungal infection
Matthew J. Robinson;Fabiola Osorio;Marcela Rosas;Rui P. Freitas.
Journal of Experimental Medicine (2009)
Impaired IgG-Dependent Anaphylaxis and Arthus Reaction in FcγRIII (CD16) Deficient Mice
Wouter L.W Hazenbos;J.Engelbert Gessner;Frans M.A Hofhuis;Henri Kuipers.
Antigenic modulation limits the efficacy of anti-CD20 antibodies: implications for antibody selection
Stephen A. Beers;Ruth R. French;H. T. Claude Chan;Sean H. Lim.
Antigen-Antibody Immune Complexes Empower Dendritic Cells to Efficiently Prime Specific CD8+ CTL Responses In Vivo
Danita H. Schuurhuis;Andreea Ioan-Facsinay;Bas Nagelkerken;Jolien J. van Schip.
Journal of Immunology (2002)
Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes
Leendert A. Trouw;Tom W.L. Groeneveld;Marc A. Seelen;Jacques M.G.J. Duijs.
Journal of Clinical Investigation (2004)
Complement Activation Selectively Potentiates the Pathogenicity of the IgG2b and IgG3 Isotypes of a High Affinity Anti-Erythrocyte Autoantibody
Samareh Azeredo da Silveira;Shuichi Kikuchi;Liliane Fossati-Jimack;Thomas Moll.
Journal of Experimental Medicine (2002)
Immunoglobulin-free light chains elicit immediate hypersensitivity-like responses.
Frank A Redegeld;Maurice W van der Heijden;Mirjam Kool;Bianca M Heijdra.
Nature Medicine (2002)
Interaction with FcγRIIB Is Critical for the Agonistic Activity of Anti-CD40 Monoclonal Antibody
Ann L. White;H. T. Claude Chan;Ali Roghanian;Ruth R. French.
Journal of Immunology (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: